Meningococcal infections in France: Data of the National Reference Center;Les infections à méningocoques en France: Les données du Centre National de Référence

Medecine Therapeutique Pediatrie

Volumn 5, Issue 4-5, 2002, Pages 191-195

  Alonso, Jean Michel ^a   Taha, Muhamed Kheir ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FRANCE; HUMAN; MENINGOCOCCOSIS; SHORT SURVEY;

EID: 0036666908     PISSN: 12865494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. Taha M-K, Deghmane AE, Antignac A, Zarantonelli ML, Larribe M Alonso J-M. The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiol 2002; 10: 376-82.
2. Cartwright K. Meningococcal carriage and disease. In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley and Son, 1995: 115-46.
3. Quagliarello V, Scheld MW. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992; 327: 864-72.
4. van Deuren M, Brandzaeg P, van der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-66.
5. Nassif X, Bourdoulous S, Eugène E, Couraud P-O. How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol 2002; 10: 227-32.
6. Noah N, Henderson, B. Surveillance of bacterial meningitis in Europe 1999-2000. 2001: PHLS, UK.
7. Hubert B, Watier L, Garnerin P, Richardson S. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 1992; 166: 542-5.
8. Taha M-K. Molecular detection and characterization of Neisseria meningitidis. Expert Rev Mol Diag 2002; 2: 143-50.
9. Caugant D. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998; 106: 505-25.
10. Taha M-K, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000; 356: 2159.
11. Antignac A, Alonso J-M Taha M-K. Le point sur la résistance de Neisseria meningitidis aux antibiotiques, d'après les souches étudiées au Centre National de Référence des Méningocoques en 1998. Antibiotiques 2000; 2: 241-5.
12. Quagliarello VJ, Scheld WM. Drug therapy: Treatment of bacterial meningitis. N Engl J Med 1997; 336: 708-16.
13. Hieber JP, Nelson JD. A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med 1977; 297: 410-13.
14. Kriz P, Giorgini D, Musilek M, Larribe M, Taha M-K. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res Microbiol 1999; 150: 273-80.